- Home
- FLL vs SGMT Comparison
FLL vs SGMT Comparison
Compare FLL & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLL
- SGMT
- Stock Information
- Founded
- FLL 1987
- SGMT 2006
- Country
- FLL United States
- SGMT United States
- Employees
- FLL N/A
- SGMT N/A
- Industry
- FLL Hotels/Resorts
- SGMT
- Sector
- FLL Consumer Discretionary
- SGMT
- Exchange
- FLL Nasdaq
- SGMT Nasdaq
- Market Cap
- FLL 165.2M
- SGMT 165.4M
- IPO Year
- FLL 1993
- SGMT 2023
- Fundamental
- Price
- FLL $5.33
- SGMT $4.12
- Analyst Decision
- FLL Strong Buy
- SGMT Strong Buy
- Analyst Count
- FLL 4
- SGMT 7
- Target Price
- FLL $6.50
- SGMT $25.71
- AVG Volume (30 Days)
- FLL 156.7K
- SGMT 877.5K
- Earning Date
- FLL 03-06-2025
- SGMT 03-24-2025
- Dividend Yield
- FLL N/A
- SGMT N/A
- EPS Growth
- FLL N/A
- SGMT N/A
- EPS
- FLL N/A
- SGMT N/A
- Revenue
- FLL $279,132,000.00
- SGMT N/A
- Revenue This Year
- FLL $23.82
- SGMT N/A
- Revenue Next Year
- FLL $11.07
- SGMT N/A
- P/E Ratio
- FLL N/A
- SGMT N/A
- Revenue Growth
- FLL 28.57
- SGMT N/A
- 52 Week Low
- FLL $3.77
- SGMT $2.39
- 52 Week High
- FLL $5.94
- SGMT $7.64
- Technical
- Relative Strength Index (RSI)
- FLL 60.18
- SGMT 43.11
- Support Level
- FLL $5.10
- SGMT $3.96
- Resistance Level
- FLL $5.56
- SGMT $4.83
- Average True Range (ATR)
- FLL 0.19
- SGMT 0.38
- MACD
- FLL -0.02
- SGMT -0.04
- Stochastic Oscillator
- FLL 58.18
- SGMT 13.39
About FLL Full House Resorts Inc.
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).